Navigation Links
GenoLogics' Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform

VICTORIA, BC, Sept. 5 /PRNewswire/ - GenoLogics, a leading developer of lab and data management software solutions for life sciences research, announced today the Company has joined the Affymetrix GeneChip-compatible(TM) Applications Program, and its Geneus product has achieved GeneChip-compatible(TM) status with the Affymetrix, Inc. (Nasdaq: AFFX) GeneChip(R) microarray platform. GenoLogics has seamlessly integrated its Geneus solution, built for multiple genomics applications, with the Affymetrix GeneChip(R) platforms, GeneChip Operating Software (GCOS) and the new GeneChip(R) Command Console(TM) Software (AGCC).

Since mid-last year the GenoLogics team has been working closely with Affymetrix' development team, to ensure the development of a seamless integration that enables bi-lateral communication between Geneus and the Affymetrix GeneChip microarray platform.

Geneus, a LIMS and scientific data management system (SDMS) purposed for multiple genomics application areas, is built on an adaptable and configurable platform. The Geneus software allows for smooth data flow from one system to another and acts as the informatics backbone for one or multiple labs.

Steve Lincoln, vice president of Informatics at Affymetrix said, "We are pleased to welcome GenoLogics' Geneus into the GeneChip-compatible family of applications. Geneus' integration with the Affymetrix platform allows customers to streamline and scale-up their microarray-based science more efficiently and cost-effectively."

Jason Wilson, product manager at GenoLogics commented, "I am very excited about our GeneChip application partnership with Affymetrix. This high value integration aligns with our strategy to bridge the connectivity gap for researchers with a LIMS and SDMS that interconnects their entire lab with their Affymetrix GeneChip technology."

"We are delighted that we are now a member of Affymetrix' GeneChip-compatible applications program and we look forward to a close ongoing relationship with them. Our partnership with Affymetrix extends our growing network of strategic partners. Strong relationships with best-in-class vendors enable us to provide solutions that are deeply purposed for variety of emerging life sciences applications," commented Michael Ball, GenoLogics CEO.

About GenoLogics

GenoLogics is the leading provider of lab informatics software solutions that help life science laboratories specializing in the field of proteomics, genomics and other research, to manage, integrate and analyze enormous volumes of scientific and lab data. The Company's mission is to catalyze life sciences research with a collaborative data management software platform, advancing the early detection, prevention and treatment of disease. For more information, visit

About the Affymetrix Developer' Network (ADN)

Through one of the largest third party software developer communities within the life sciences industry, Affymetrix works with its software developers to provide a broad spectrum of solutions for leveraging gene expression and genetic variation analysis in both biomedical research and development. Membership in ADN is free of charge for both commercial and academic software developers. For more information please visit,

About Affymetrix

Affymetrix GeneChip(R) microarray technology is the industry-standard tool for analyzing complex genetic information. After inventing microarray technology in the late 1980s, Affymetrix scientists have been dedicated to developing innovative products that provide researchers with a more complete view of the genome. These products continue to accelerate genetic research and enable scientists to develop diagnostics and tailor treatments for individual patients by identifying and measuring the genetic information associated with complex diseases.

Today, Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies, as well as leading academic, government and not-for-profit research institutes. More than 1,600 systems have been shipped around the world and more than 9,500 peer-reviewed papers have been published using the technology.

Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing facilities in Sacramento, Calif., and Singapore. The company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe and Asia. For more information about Affymetrix, please visit:

CONTACT: Tanis MacSween, Marketing Communications Manager, GenoLogics Life Sciences Software, Inc., Tel: (250) 483-7063, email:

SOURCE GenoLogics Life Sciences Software Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Inacom Information Systems achieves Cisco Systems Partner -Gold Certified status
2. Third Wave Achieves Milestone, Delivers 200,000 SNP Assays to RIKEN In Japan
3. U.S. risks third-world status in key technology
4. Massachusetts stem-cell plan reflects status quo for Wisconsin research
5. Fine Tuning Your Data Analysis: Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms
6. The Affymetrix GeneChip Scanner 3000 New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range
7. The New Affymetrix GeneChip Scanner 3000
8. New Microarray Labeling Kit for Preparing cDNA Probes
9. Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
10. An Optimal DNA Microarray Substrate for the Identification of Fetal and Somatic Liver Stem Cells of the Rat
11. Amplification of Mouse cDNAs for Microarrays Using the Eppendorf MasterTaq Kit
Post Your Comments:
(Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica ... on AngelList early in their initial angel funding process. Now, they are paying ... looking to make early stage investments in the microbiome space. In this, ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
Breaking Biology Technology:
(Date:11/20/2015)... OXFORD, Connecticut , November 20, 2015 ... biometric authentication company focused on the growing mobile commerce ... its CEO, Gino Pereira , was recently interviewed ... The interview will air on this weekend on ... Bloomberg Latin America . --> NXTD ) ...
(Date:11/17/2015)... 17, 2015 Paris from ... --> Paris from 17 th until ... biometrics innovation leader, has invented the first combined scanner in ... same scanning surface. Until now two different scanners were required: ... can capture both on the same surface. This innovation ...
(Date:11/12/2015)...  A golden retriever that stayed healthy despite having ... provided a new lead for treating this muscle-wasting disorder, ... of MIT and Harvard and the University of São ... Cell, pinpoints a protective gene that boosts ... The Boston Children,s lab of Lou Kunkel , ...
Breaking Biology News(10 mins):